The application of the linear-quadratic model to fractionated radiotherapy when there is incomplete normal tissue recovery between fractions, and possible implications for treatments involving multiple fractions per day

The British Journal of Radiology
Roger Dale

Abstract

By extending a previously developed mathematical model based on the linear-quadratic dose-effect relationship, it is possible to examine the consequences of performing fractionated treatments for which there is insufficient time between fractions to allow complete damage repair. Equations are derived which give the relative effectiveness of such treatments in terms of tissue-repair constants (mu values) and alpha/beta ratios, and these are then applied to some examples of treatments involving multiple fractions per day. The interplay of the various mechanisms involved (including repopulation effects) and their possible influence on treatments involving closely spaced fractions are examined. If current indications of the differences in recovery rates between early- and late-reacting normal tissues are representative, then it is shown that such differences may limit the clinical potential of accelerated fractionation regimes, where several fractions per day are given in a relatively short overall time.

References

Nov 1, 1975·Annals of Internal Medicine·M J ClineJ L Fahey
Jun 1, 1975·The British Journal of Radiology·B G Douglas, J F Fowler
Sep 1, 1985·The British Journal of Radiology·J H Hendry, J V Moore
Mar 1, 1985·International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine·H D Thames
Jan 1, 1985·International Journal of Radiation Oncology, Biology, Physics·M V WilliamsJ F Fowler
Jul 1, 1985·International Journal of Radiation Oncology, Biology, Physics·T H KimC R Freeman
Nov 1, 1985·International Journal of Radiation Oncology, Biology, Physics·K K AngE van der Schueren
May 1, 1973·The British Journal of Radiology·J Denekamp
Jan 1, 1973·Physics in Medicine and Biology·K H Chadwick, H P Leenhouts
Feb 1, 1971·The British Journal of Radiology·W E Liversage
Aug 1, 1984·International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine·J F Fowler
Oct 1, 1984·International Journal of Radiation Oncology, Biology, Physics·S L Tucker
Jan 1, 1984·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·A Michalowski
Jan 1, 1984·International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine·H D Thames
Nov 1, 1982·International Journal of Radiation Oncology, Biology, Physics·G W Barendsen
Feb 1, 1983·International Journal of Radiation Oncology, Biology, Physics·H D ThamesG H Fletcher
Feb 1, 1982·International Journal of Radiation Oncology, Biology, Physics·H D ThamesG H Fletcher

❮ Previous
Next ❯

Citations

Oct 1, 1987·The British Journal of Radiology·O C Scott
Aug 1, 1997·The British Journal of Radiology·P A Canney, W T Millar
Mar 1, 1989·The British Journal of Radiology·A Courdi
Jan 1, 1993·The British Journal of Radiology·T E WheldonA Barrett
Jul 7, 2010·The British Journal of Radiology·J F Fowler
Oct 12, 2010·Bone Marrow Transplantation·J A PeñagarícanoV Ratanatharathorn
Apr 7, 1999·International Journal of Radiation Oncology, Biology, Physics·A Daşu, J Denekamp
Oct 1, 1996·International Journal of Radiation Oncology, Biology, Physics·R G Dale, B Jones
Apr 1, 1997·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S M JacksonJ S Durham
Feb 1, 1997·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·G StübenE van der Schueren
Nov 19, 1997·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·K HaustermansE van der Schueren
Nov 19, 1997·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·W LanduytE van der Schueren
Dec 1, 1996·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·W DuncanD Downing
Feb 1, 1996·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·L A PopA J van der Kogel
Jan 5, 2002·Australasian Physical & Engineering Sciences in Medicine·L JonesP Metcalfe
Jun 11, 2005·Journal of Neurosurgery. Spine·Jeffrey W DegenFraser C Henderson
Jun 7, 2005·International Journal of Radiation Oncology, Biology, Physics·Clinton S ParkPing Xia
Jan 1, 1993·International Journal of Radiation Biology·J Y Ostashevsky
Jun 12, 2013·International Journal of Radiation Oncology, Biology, Physics·Yutaka ShiraishiNaoyuki Shigematsu
May 29, 2012·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Mihai LevitchiDidier Peiffert
Sep 30, 1994·International Journal of Radiation Oncology, Biology, Physics·J M CossetE Gluckman
Oct 1, 1991·International Journal of Radiation Oncology, Biology, Physics·A HerskovicJ Holt
May 1, 1990·International Journal of Radiation Oncology, Biology, Physics·J F Fowler
Mar 1, 1990·International Journal of Radiation Oncology, Biology, Physics·B N GrayL Matz
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·E ArmourA Martinez
Nov 1, 1988·International Journal of Radiation Oncology, Biology, Physics·E van RongenA J van der Kogel
Jul 10, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Christine Haie-MederNicolas Magné
Sep 9, 2008·International Journal of Radiation Oncology, Biology, Physics·Cyrus ChargariChristine Haie-Meder
Nov 27, 2007·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Marisol De BrabandereErik Van Limbergen
Oct 3, 2006·International Journal of Radiation Oncology, Biology, Physics·Michael B AltmanJohn C Roeske
May 1, 1990·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·R GuttenbergerD Chmelevsky
Jan 1, 1991·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·G StübenA Reijnders
Feb 1, 1992·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·G J van den Aardweg, J W Hopewell
Jun 1, 1989·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J M CossetJ Dutreix
Aug 1, 1989·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·R G Dale
Jun 7, 2013·International Journal of Radiation Biology·Vadim Y Kuperman, Greg S Spradlin
Mar 2, 2018·The British Journal of Radiology·Charlotte Demoor-GoldschmidtFlorent de Vathaire

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.